Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SJ-C1044 |
| Synonyms | |
| Therapy Description |
SJ-C1044 is a pan-RAF inhibitor, which potentially decreases immune suppression and tumor growth (PMID: 37504287). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SJ-C1044 | SJ C1044|SJC1044 | RAF Inhibitor (Pan) 29 | SJ-C1044 is a pan-RAF inhibitor, which potentially decreases immune suppression and tumor growth (PMID: 37504287). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| BRAF V600E | colorectal cancer | sensitive | SJ-C1044 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, SJ-C1044 decreased growth in a colorectal cancer cell line harboring BRAF V600E in culture and inhibited tumor growth in a cell line xenograft model (PMID: 37504287). | 37504287 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|